Research data ยท Motor function and endurance

Grid walking (foot fault)

From 2021 to 2025, 155 animal research papers mentioned grid walking (foot fault) in their title or abstract, ranking it 47th of the 90 tests we track.

That is 1.4 times the 109 papers of 2011 to 2015. Papers that mention any of the 90 tests grew to 1.2 times as many over the same span.

155 animal research papers from 2021 to 2025 mentioned the test
1.4 times as many papers as in 2011 to 2015
47th of the 90 tests by papers from 2021 to 2025
55% of these papers used mice and 48% used rats

Papers by year

Animal research papers that mention grid walking (foot fault), by year, 2001 to 2026

The 2026 bar counts papers added to PubMed by November 8, 2026.

  • Papers in a full year
  • 2026 so far
Show the counts for each year
Papers by year
YearPapers
20014
20027
20033
20045
20057
200613
20079
200816
200913
201019
201119
201224
201320
201426
201520
201620
201729
201829
201936
202036
202134
202225
202336
202430
202530
2026 (part year)34

Papers that mention grid walking (foot fault) fell from 34 in 2021 to 25 in 2022, then rose to 30 in 2025. Papers that PubMed indexed under the MeSH heading Animals also fell and rose, from 200,221 in 2021 to 156,447 in 2023 and 235,479 in 2025. We take each paper's species from PubMed's indexing whenever it names one, so part of this dip may come from the indexing rather than from fewer studies.

Papers that mention grid walking (foot fault) in mice and in rats, by year, 2001 to 2025

  • Mouse
  • Rat
Show the counts for each year and species
Papers by year, mice and rats
YearMouseRat
200113
200216
200303
200423
200525
2006211
200718
2008710
2009112
2010415
2011712
2012620
2013714
2014917
2015317
2016515
2017919
20181119
20191522
20202017
20211718
20221412
20231819
20241614
20252012

Which species the papers used

Each bar is a share of the 155 papers from 2021 to 2025. A paper can use more than one species, so the shares can add to more than 100%.

Species

Mouse
85 papers 55%
Rat
75 papers 48%
Other animals
2 papers 1%

โ€œOther animalsโ€ counts papers that use none of the other species in this chart.

Strains and genetic lines

Strain names come from the MeSH terms PubMed adds when it indexes a paper. PubMed has indexed 124 of the 155 papers, so each bar is a share of those 124.

C57BL mice
39 papers 31%
Sprague-Dawley rats
33 papers 27%
Knockout mice
8 papers 6%
Wistar rats
6 papers 5%
Transgenic mice
3 papers 2%
Spontaneously hypertensive rats
2 papers 2%
BALB/c mice
1 paper 1%
Long-Evans rats
1 paper 1%

A paper indexed under two of these headings, such as knockout mice and a strain, counts under both.

Disease models these papers study

Each bar counts the papers from 2021 to 2025 that mention grid walking (foot fault) and study that disease model, with its share of the 155 papers. The model comes from a paper's MeSH terms. For a paper PubMed has not indexed, it comes from PubTator 3, NCBI's text-mining service, when that service finds the disease in the title or abstract. A paper can count under more than one model.

Papers from 2021 to 2025 by disease model

Tests mentioned alongside grid walking (foot fault)

Each bar counts the papers from 2021 to 2025 that mention both tests, with its share of the 155 papers that mention grid walking (foot fault).

Papers from 2021 to 2025 that mention both tests

37 papers 24%
23 papers 15%
17 papers 11%
11 papers 7%
7 papers 5%

The most cited papers from 2021 to 2025

These papers from 2021 to 2025 mention grid walking (foot fault) and have the most citations, as counted by NIH's iCite on November 5, 2026.

  1. Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury.

    J Neuroinflammation, 2021. 105 citations.

  2. A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage.

    J Ethnopharmacol, 2024. 78 citations.

  3. Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization.

    CNS Neurosci Ther, 2022. 72 citations.

  4. Transcranial Direct Current Stimulation Enhances Neuroplasticity and Accelerates Motor Recovery in a Stroke Mouse Model.

    Stroke, 2022. 71 citations.

  5. Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury.

    Pharm Biol, 2023. 69 citations.

How we counted

A count is the number of animal research papers whose title or abstract mentions one of the test's search terms. It is not a count of experiments, labs or animals.

A paper that mentions grid walking (foot fault) only in its methods is missed, so the count runs low. The count includes 3 reviews. For 31 of the 155 papers, PubMed's indexing gave no species, so the species came from PubTator 3 finding one in the title or abstract.

The test's search terms are in the test list download. The full method, with each source and its terms of use, is on our main page, Behavioral tests in published research.

More motor function and endurance tests

These motor function and endurance tests also have a page, with their papers from 2021 to 2025. Each test with 30 or more papers gets one.

How to cite

APA

ConductScience. (2026, November 10). Grid walking (foot fault) in published research [Data set]. https://conductscience.com/data/behavioral-tests/grid-walking

BibTeX

@misc{conductscience_grid_walking_2026,
  author = {{ConductScience}},
  title = {Grid walking (foot fault) in published research},
  year = {2026},
  month = nov,
  url = {https://conductscience.com/data/behavioral-tests/grid-walking},
  note = {Data set, released November 10, 2026},
}

Apparatus for grid walking (foot fault)

Our store sells two products for grid walking (foot fault).

Shop the apparatus

Papers that name our apparatus

We keep our own list of published papers whose text names our equipment. Those that mention grid walking (foot fault) in the title or abstract are already in the counts above.